Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Adeshwar Meditex Ltd - 543309 - Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations. 2015

 In terms of Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, enclosed please find disclosures received from Mr. Shreyas Sampatkumar Jajoo, one of the insider being Chief Financial Officer (KMP) of the company, in Form ''C'' pursuant to Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding: 1. Sale of 12,000 equity shares of the company on 19-05-2022. Please take aforesaid disclosures on record and oblige.
20-05-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th May, 2022

 We enclose herewith the audited standalone and consolidated financial results of the Company for the quarter and year ended 31st March, 2022, which have been approved and taken on record at the meeting of the Board of Directors of the Company held today, the 13th May, 2022. The standalone Balance Sheet of the Company as at March 31, 2022, the Statement of Profit and Loss account and the Cash Flow Statement for the year ended on that date were also approved and adopted at the Board Meeting. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), read with SEBI Circular CIR/CFD/CMD/56/2016 dated 27th May, 2016 on "Disclosure of the Impact of Audit Qualifications by the Listed Entities", we would like to confirm that M/s. J. N. Gupta & Co., Chartered Accountants (Firm Registration no. 006569C), Statutory Auditors of the Company, have issued Audit Reports with unmodified opinion on the above financial results.
13-05-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Half -Yearly Compliances-Statement Of Deviation(S) Or Variation(S) And Annual Disclosure.

 Dear Sir/Madam, Pursuant to Regulation 32(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed a statement showing any deviation or variation as on March 31, 2022 from utilization of funds raised through public issue. Kindly take the document on record and acknowledge the receipt.
09-05-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Board Meeting Intimation for Intimation Of Board Meeting For The Audited Financial Results For The Half Year And Financial Year Ended March 31, 2022 And Inter Alia

 Adeshwar Meditex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2022 ,inter alia, to consider and approve We wish to inform you that the meeting of the Board of Directors of the Company will be held on Friday, May 13, 2022 at the Registered Office of the Company at 68, Atlanta Bldg, J.B. Marg, Nariman Point, Mumbai- 400 002, Maharashtra, India at 02:30 P.M., inter alia, to consider and approve: To consider and approve the Standalone Audited Financial Result of the Company along with auditor's report for the half year and financial year ended 31st March, 2022; To consider and approve the Standalone Audited financial statements for the financial year ended 31st March 2022; To take on record auditor's report on Audited financial statements for the financial year ended 31st March 2022; Any other matter with the permission of the Chair.
05-05-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Submission Of Compliance Certificate Of The Company In Terms Of Regulation 40(9) Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015

 Dear Sir, Please find enclosed the compliance certificate of the company in terms of Regulation 40(9) of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, received from the Practicing Company Secretary for the year ended on 31st March, 2022, for your kind perusal and Records. Kindly take the note of the same.
15-04-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2022

 Pursuant to the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby certify that all activities in relation to both physical and electronic share transfer facility are maintained by our Share Transfer Agent viz. Bigshare Services Pvt. Ltd. having permanent SEBI Registration No: INR000001385 Kindly take note of the above.
14-04-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In reference to the above subject and captioned regulation we hereby confirm that the securities received if any from the depository Participants for dematerialization, were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchange where the earlier issued securities are listed. We hereby confirm that the security certificates received if any for dematerialization have been mutilated & cancelled after due verification by the depository Participant and the name of the depositories have been substituted in register of members as registered owner within 15 days of receipt of certificate of securities. We request you to kindly take note of the above in your records.
13-04-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Statement Of Investor Complaints For The Quarter Ended March 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Shivani TiwariDesignation :- Company Secretary and Compliance Officer
13-04-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Regulation 31 (4) SEBI (Substantial Acquisition Of Shares And Takeover) Regulation, 2011

 Please find enclosed the yearly disclosure under regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011, as amended, received from the Promoter & Promoters Group of the Company for the year ended on 31st March, 2022, for your kind perusal and Records.
07-04-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Closure of Trading Window

 With reference to the above subject, this is to inform that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and the clarification from BSE dated April 02, 2019 vide Circular Reference no. LIST/COMP/01/2019-20, Trading Window for dealing in Securities of the Company will remain closed for all Directors, Officers, Designated Persons of the Company and their immediate relatives with effect from Friday, April 01, 2022 till 48 hours after the declaration of Audited Financial Results of the Company for the quarter and half year ended March 31, 2022. The date of meeting of Board of Directors to approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2022 will be informed in due course.
29-03-2022
Next Page
Close

Let's Open Free Demat Account